Results 61 to 70 of about 3,179,078 (198)

Real-world outpatient parenteral antimicrobial therapy before national reimbursement: a retrospective cohort study from a Taiwanese cancer hospital

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Before Taiwan’s national outpatient parenteral antimicrobial therapy (OPAT) reimbursement, we retrospectively evaluated 241 OPAT episodes among 173 patients at a cancer hospital.
Kai-Ming Chang   +7 more
doaj   +1 more source

Real‐World Use of Rezafungin for the Treatment of Challenging Aspergillus Infections

open access: yesMycoses, Volume 69, Issue 11, November 2026.
ABSTRACT Background Aspergillus infections can pose significant treatment challenges, due in part to increasing triazole resistance. Clinical insight is needed to understand the potential for rezafungin, a next‐generation echinocandin with once‐weekly dosing, to address some limitations of current treatments for Aspergillus infections.
Neil Stone   +9 more
wiley   +1 more source

Cenobamate use in super‐refractory status epilepticus: A report of three cases

open access: yesEpileptic Disorders, Volume 28, Issue 5, Page 1661-1668, October 2026.
Abstract Objectives Super‐refractory status epilepticus (SRSE) is a neurological emergency with high morbidity and mortality. Cenobamate, a novel antiseizure medication, may be helpful in managing SRSE, but evidence is limited. Methods This retrospective case series reports the use of cenobamate as add‐on therapy in the management of three cases of ...
Marina Romozzi   +11 more
wiley   +1 more source

Health-Related Quality of Life in Outpatient Parenteral Antimicrobial Therapy

open access: yes, 2018
Health-related quality of life (HRQoL) in outpatient parenteral antimicrobial therapy (OPAT) has not been well characterized in the United States. In an OPAT cohort, the short-form-12’s median physical component score and mental component score were 40.3
Sara C Keller   +3 more
core   +1 more source

Inappropriateness of Intravenous Antibiotic Prescriptions at Hospital Discharge at a Tertiary Care hospital in Thailand

open access: yesDrug, Healthcare and Patient Safety, 2019
Tuanjai Mahatumarat,1 Napaporn Pinmanee,2 Wichchulada Injai,2 Romanee Chaiwarith1 1Division of Infectious Diseases, Department of Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 2Division of Pharmacy, Maharaj Nakorn Chiang Mai
Mahatumarat T   +3 more
doaj  

A data-driven financial justification for an outpatient infectious diseases pharmacist

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
We present a financial justification for an outpatient infectious diseases pharmacist, based on cost savings from decreases in length of stay for patients with Staphylococcus aureus infections and additional revenue generated by physicians and ...
Justin J. Kim   +4 more
doaj   +1 more source

A Rare Finding of Retroperitoneal Sepsis Following Robot‐Assisted Transanal Minimally Invasive Surgery (TAMIS): A Case Report and Review of the Literature

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Robot‐assisted transanal minimally invasive surgery (TAMIS) is a safe and effective platform for the local excision of early rectal lesions. While postoperative complications such as bleeding or contained perforation are recognized, rapidly progressive retroperitoneal sepsis remains an exceedingly rare occurrence.
Jonathan Tiong   +4 more
wiley   +1 more source

Palliative outpatient parenteral antimicrobial therapy (OPAT): A single center experience and systematic scoping review

open access: yesClinical Infection in Practice, 2022
Traditionally, outpatient parenteral antimicrobial therapy (OPAT) is used to treat infections with predictable course and anticipated response to therapy. However, there has been little consideration of OPAT for palliation as opposed to cure.
Oyewole Chris Durojaiye   +2 more
doaj   +1 more source

To Discharge or Not to Discharge on Outpatient Parenteral Antimicrobial Therapy: That Is the Question [PDF]

open access: yesHospital Pediatrics, 2019
Outpatient parenteral antimicrobial therapy (OPAT) has gained traction since the 1970s as a means of delivering intravenous (IV) antibiotic therapy in home or ambulatory settings. OPAT is relatively safe and more cost-effective than hospital administration of IV antibiotics.1–4 Yet the initiation of OPAT requires thoughtful consideration of individual ...
Jessica L, Markham, Jennifer L, Goldman
openaire   +2 more sources

Dose Selection for Ceftibuten Combined with Avibactam Tomilopil, a Potential Oral Alternative to Carbapenems for Patients with Complicated Urinary Tract Infections

open access: yesThe Journal of Clinical Pharmacology, Volume 66, Issue 9, September 2026.
Abstract There are currently no oral treatment options for infections caused by extended spectrum β‑lactamase‐producing Enterobacterales. Avibactam tomilopil, a novel oral prodrug of avibactam, is being developed in combination with the oral cephalosporin, ceftibuten, as a potential treatment for patients with complicated urinary tract infections ...
Siddhee A. Sahasrabudhe   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy